Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors
Abstract Background While ETV6- NTRK3 fusion is common in infantile fibrosarcoma, NTRK1/3 fusion in pediatric tumors is scarce and, consequently, not well known. Herein, we evaluated for the presence of NTRK1/3 fusion in pediatric mesenchymal tumors, clinicopathologically and immunophenotypically. M...
Main Authors: | Jeongwan Kang, Jin Woo Park, Jae-Kyung Won, Jeong Mo Bae, Jaemoon Koh, Jeemin Yim, Hongseok Yun, Seung-Ki Kim, Jung Yoon Choi, Hyoung Jin Kang, Woo Sun Kim, Joo Heon Shin, Sung-Hye Park |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13000-020-01031-w |
Similar Items
-
NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine
by: Federica Zito Marino, et al.
Published: (2020-05-01) -
A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report
by: Ning Zhou, et al.
Published: (2018-08-01) -
TMP3-NTRK1 rearranged uterine sarcoma: A case report
by: William Boyle, et al.
Published: (2020-10-01) -
Case report: NTRK1-rearranged cervical sarcoma with fibrosarcoma like morphology presenting in a 13-year-old managed with a neo-adjuvant TRK-inhibitor and surgical excision
by: E.A. Goulding, et al.
Published: (2021-08-01) -
Molecular and clinicopathologic features of gliomas harboring NTRK fusions
by: Matthew Torre, et al.
Published: (2020-07-01)